CytomX Therapeutics Inc (CTMX) earnings · rev $11.7M
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
This CTMX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
When the next CTMX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 13.8% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full CTMX research stays on the stock page; the tape stays on the quote page.
Not investment advice.